National Health Investors, Inc. (NYSE:NHI) Receives Average Rating of "Moderate Buy" from Brokerages

National Health Investors, Inc. (NYSE:NHI - Get Free Report) has been given an average recommendation of "Moderate Buy" by the six analysts that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $75.33.

A number of analysts have recently weighed in on NHI shares. Wells Fargo & Company lowered shares of National Health Investors from an "overweight" rating to an "equal weight" rating and increased their target price for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. Bank of America initiated coverage on shares of National Health Investors in a report on Tuesday, September 24th. They issued a "buy" rating and a $92.00 price objective for the company. StockNews.com cut shares of National Health Investors from a "buy" rating to a "hold" rating in a report on Tuesday, October 15th. Finally, Truist Financial cut their price target on National Health Investors from $78.00 to $72.00 and set a "hold" rating on the stock in a research note on Monday, December 23rd.

Institutional Trading of National Health Investors

Several hedge funds have recently modified their holdings of the company. Zimmer Partners LP purchased a new stake in National Health Investors during the third quarter valued at approximately $25,218,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of National Health Investors by 332.0% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 242,326 shares of the real estate investment trust's stock valued at $20,370,000 after purchasing an additional 186,238 shares during the last quarter. Charles Schwab Investment Management Inc. raised its holdings in National Health Investors by 17.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust's stock valued at $71,651,000 after buying an additional 123,596 shares during the period. Waterfront Capital Partners LLC bought a new stake in National Health Investors in the third quarter worth $10,097,000. Finally, Easterly Investment Partners LLC purchased a new position in National Health Investors during the third quarter worth $5,632,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Price Performance

National Health Investors stock traded up $0.26 during mid-day trading on Tuesday, hitting $67.30. 183,614 shares of the company traded hands, compared to its average volume of 248,428. The stock has a fifty day moving average price of $74.22 and a 200-day moving average price of $75.87. The stock has a market cap of $3.06 billion, a price-to-earnings ratio of 23.13, a price-to-earnings-growth ratio of 4.86 and a beta of 1.06. National Health Investors has a one year low of $51.59 and a one year high of $86.13. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29.

National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.42). The firm had revenue of $63.32 million for the quarter, compared to the consensus estimate of $67.93 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. National Health Investors's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter last year, the company posted $1.08 earnings per share. On average, equities analysts predict that National Health Investors will post 4.42 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.90 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.35%. National Health Investors's payout ratio is 123.71%.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.